Orthopedic devices are used to treat the disorders and injuries of the musculoskeletal system of human body. Orthobiologics are biomaterials used in orthopedic surgery as an adjunct to faster fusion and healing of the bone. Soft Tissue Biologics are used in surgical procedures to replace, reinforce, or repair tendons or ligaments that have been torn or damaged in the human body. GlobalData uses proprietary data and analytics to provide a comprehensive report on the soft tissue biologics devices market, including market shares of different players within Sweden. Buy the latest report here.

Smarter leaders trust GlobalData

Report-cover

Data Insights Sweden Soft Tissue Biologics Market Share

Buy the Report

Data Insights

The gold standard of business intelligence.

Find out more

In 2022, GlobalData’s Market Model methodology determined that the leading player in the soft tissue biologics market in Sweden was LifeNet Health followed by RTI Surgical, Arthrex, Smith & Nephew, AlloSource, Wright Medical Group, ConMed and Zimmer Biomet.

This Soft Tissue Biologics market focuses on the repair of the anterior cruciate ligament (ACL), posterior cruciate ligament (PCL), rotator cuff, and Achilles’s tendon. Other indications include medial collateral ligament (MCL), lateral collateral ligament (LCL), medial patellofemoral ligament (MPFL), ulnar collateral ligament (UCL), flexor tendon, and hip flexor repair. Soft Tissue Biologics can be either tendon grafts/reinforcements or tendon wrapping products. Tendon grafts or reinforcements are meant to provide structural aid to or replacement of the damaged tendon in order to restore normal function. Tendon Wrapping is a form of surgical tendon repair where a small sheet of tissue that acts as a physical barrier between the repair site and the surrounding space, providing a low friction environment for the tendon to heal and operate within.

Following the widespread disruption resulting from the COVID-19 pandemic to the broader medical devices market during 2020 and 2021, the value of the soft tissue biologics devices market within Sweden was expected to be over $0.9m in 2022.

For the latest complete market share analysis of soft tissue biologics device market in Sweden, buy the report here.

Data Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article. 

The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. Pipeline Products database is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.